Connect with us

Press Release

Above Food and Bite Acquisition Corp. Announce Approval of Business Combination by Above Food Shareholders

Published

on

(via TheNewswire)

Above Food Corp.

Calgary, Alberta and New York, NY – TheNewswire – June 11, 2024 — Above Food Corp. (the “Company” or “Above Food“) and Bite Acquisition Corp. (NYSE AMERICAN: BITE) (“Bite“) today announced that the Company’s shareholders have unanimously approved the previously announced plan of arrangement (the “Arrangement“) in respect of the business combination among Bite, the Company, Above Food Ingredients Inc. (“New Above Food“) and Above Merger Sub, Inc. (the “Business Combination“) at the Company’s special meeting of shareholders held on June 7, 2024 (the “Special Meeting“).

The special resolution approving the Arrangement (the “Arrangement Resolution“) was required to be approved by at least two-thirds (66 2/3%) of the votes cast by the Company’s shareholders represented in person or by proxy at the Special Meeting. A total of 53,222,427 of the Company’s common shares, representing approximately 68% of votes entitled to be cast at the Special Meeting, were represented in person or by proxy at the Special Meeting and all (100%) of the votes at the Special Meeting were voted in favour of the Arrangement Resolution.

The Special Meeting was called in accordance with the interim order granted on May 29, 2024 by the Court of King’s Bench of Alberta (the “Court“) in connection with the Arrangement. The Company will seek a final order approving the Arrangement from the Court on June 18, 2024. Closing of the Arrangement remains subject to satisfaction of certain customary closing conditions, including receipt of final Court, stock exchange and regulatory approvals.

About Above Food

Above Food Corp. is a differentiated, regenerative ingredient company that celebrates delicious products made with real nutritious, flavorful ingredients and delivered with transparency. Above Food’s vision is to create a healthier world — one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, Above Food delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food’s consumer products and brands are available online at www.abovefood.com and in leading grocers across Canada and the United States.

About Bite Acquisition Corp.

Bite Acquisition Corp is a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Bite is led by Chair and CEO Alberto Ardura and a team of successful industry executives, and venture capital investors who have long track records of operating business in the restaurant and food industries.

Cautionary Statement Regarding Forward-Looking Information

This press release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities laws (collectively “forward-looking information“), which are based on Above Food’s and Bite’s current internal expectations, estimates, projections, assumptions and beliefs. The use of any of the words “believe”, “estimate”, “anticipate”, “expect”, “plan”, “predict”, “outlook”, “target”, “project”, “plan”, “may”, “could”, “will”, “shall”, “should”, “intend”, “potential”, “seek”, “future”, “outlook” and similar expressions that predict or indicate future events or trends or events that are not statements of historical matters are intended to identify forward-looking information. Forward-looking information in this press release includes, but is not limited to: statements regarding the anticipated benefits of the Business Combination, particularly that the Business Combination will offer certain advantages to Above Food’s shareholders and Bite stockholders; the expectation that following completion of the Business Combination, the Above Food’s shareholders and Bite stockholders will continue to participate in the upside of the combined company; and statements regarding estimates and forecasts of financial and performance metrics and projections of market opportunity. Forward-looking information is not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability.

Above Food and Bite currently believe the expectations reflected in the forward-looking information in this press release are reasonable, but no assurance can be given that these expectations will prove to be correct, and readers should not place undue reliance on such forward-looking information. The forward-looking information in this press release is subject to a number of known and unknown risks and uncertainties that could cause actual events or results to differ materially, including, but not limited to: (i) changes in domestic and foreign business, market, financial, political and legal conditions; (ii) the inability of the parties to successfully or timely consummate the proposed Business Combination, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company, the expected benefits of the proposed Business Combination are not obtained or that any of the conditions to closing are not satisfied or that events or other circumstances give rise to the termination of the business combination agreement relating to the proposed Business Combination; (iii) changes to the structure of the proposed Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining the necessary regulatory approvals; (iv) the ability to meet stock exchange listing standards following the consummation of the proposed Business Combination; (v) the risk that the proposed Business Combination disrupts current plans and operations of Above Food as a result of the announcement and consummation of the proposed Business Combination; (vi) failure to realize the anticipated benefits of the proposed Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (vii) costs related to the proposed Business Combination; (viii) changes in applicable law or regulations; (ix) risks relating to the uncertainty of the projected financial information with respect to Above Food; (x) the outcome of any legal proceedings that may be instituted against Bite or Above Food; (xi) the effects of competition on Above Food’s future business; (xii) the impact of the COVID-19 pandemic on Above Food’s business; (xiii) the ability of Bite or the combined company to issue equity or equity-linked securities or obtain debt financing in connection with the proposed Business Combination or in the future; (xiv) the enforceability of Above Food’s intellectual property rights, including its copyrights, patents, trademarks and trade secrets, and the potential infringement on the intellectual property rights of others; (xv) Above Food’s ability to execute its planned acquisition strategy, including to successfully integrate completed acquisitions and realize anticipated synergies; and (xvi) those factors discussed under the heading “Risk Factors” in Bite’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission (the “SEC“) on March 11, 2024, the definitive proxy statement/prospectus filed on April 9, 2024 by Bite and New Above Food and other documents filed, or to be filed, by Bite and/or New Above Food with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by the forward-looking information. There may be additional risks that none of Bite or Above Food presently know or that Bite or Above Food currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking information.

In addition, forward-looking information reflects Bite’s and Above Food’s expectations, plans or forecasts of future events and views as of the date of this press release. Bite and Above Food anticipate that subsequent events and developments may cause Bite’s and Above Food’s assessments to change. However, while Bite and Above Food may elect to update the forward-looking information at some point in the future, Bite and Above Food specifically disclaim any obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Nothing in this press release should be regarded as a representation by any person that the forward-looking information set forth herein will be achieved or that any of the contemplated results of such forward-looking information will be achieved. Accordingly, undue reliance should not be placed upon the forward-looking information. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement.

Contacts Media:

media@abovefood.com

Investors:

investors@abovefood.com

Copyright (c) 2024 TheNewswire – All rights reserved.

comtex tracking

COMTEX_453656625/2895/2024-06-11T08:31:44

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

DEPH Labs Partners with GB Top Team to Bring AI-Powered Precision Health to Elite MMA Athletes

Published

on

London, UK, October 30th, 2026, FinanceWire

Partnership will explore how DNA, epigenetic testing and personalized biological insights can help fighters better understand their health, recovery and long-term performance

DEPH Labs, a precision health company using DNA, epigenetics and AI to turn complex biological data into personalized, actionable health insights, today announced a partnership with Great Britain Top Team (GBTT), one of the UK’s leading mixed martial arts (MMA) training organizations. The partnership is geared towards bringing advanced biological testing and personalized health insights into the world of elite combat sports.

https://youtube.com/shorts/D09WepT5q6M?feature=share

The partnership extends DEPH Labs’ proprietary precision health technology to GBTT’s team of professional MMA fighters who regularly compete at the highest level internationally in promotions such as the Ultimate Fighting Championship (UFC), Cage Warriors and the Professional Fighters League (PFL). The collaboration aims to give athletes a deeper understanding of their individual biology, helping them make more informed decisions about training, recovery, nutrition and long-term wellbeing.

Founded in 2019 and led by former UFC fighter Brad “One Punch” Pickett, Great Britain Top Team has established itself as a leading training destination for professional and aspiring MMA athletes. The organization is also home to one of the UK’s largest professional female MMA teams, making it a natural fit for DEPH Labs’ work in sex-specific biological testing.

DEPH Labs’ epigenetic testing technology includes the world’s first biological age platform developed entirely using single-sex data. Unlike conventional biological age models that combine male and female data, DEPH Labs’ approach accounts for differences in how men and women age, creating opportunities for more personalized health and performance insights.

Through at-home saliva testing and AI-powered analysis, DEPH Labs is helping athletes better understand their biological age and track how their bodies respond to the demands of professional training. Repeated epigenetic testing can also help identify changes in biological markers over time, providing another way to assess whether adjustments to training, nutrition, sleep and recovery routines are associated with measurable improvements.

For MMA athletes, these insights could be particularly valuable. Professional fighters face intense physical demands, from repeated training camps and weight management to recovery between bouts. While traditional performance testing can capture an athlete’s current condition, epigenetic analysis offers an additional perspective on how their biology may be changing over longer periods.

“Elite athletes spend an enormous amount of time trying to get the best out of their bodies, but there’s still so much we don’t understand about how individuals respond to training, recovery and nutrition,” said Lisa Loud, CEO of DEPH Labs. “DNA gives us a great foundation, but it doesn’t tell the whole story. By combining epigenetic testing with AI, we can help fighters understand how their biology is changing and whether the decisions they’re making are actually working. Partnering with GB Top Team gives us an exciting opportunity to bring that technology into one of the most physically demanding sports in the world.”

“We’re always looking for ways to give our fighters an edge, and understanding what’s happening inside their bodies is a big part of that,” said Brad Pickett UFC veteran & Co-Founder of Great Britain Top Team. “Training hard is one thing, but knowing how your body responds to that training is just as important. Working with DEPH Labs gives us a rare opportunity to use DNA and epigenetic testing to better understand recovery, performance and long-term health. Every fighter is different, and the more we can personalize their training and preparation, the better.”

The collaboration also reflects a growing interest in applying precision health technology beyond traditional healthcare settings. Rather than relying on generalized recommendations, DEPH Labs aims to make personalized biological insights accessible to individuals who want to better understand their health, whether they’re professional athletes or everyday consumers. DEPH Labs is bringing this technology to consumers through ENGNE, its men’s health and longevity platform, and UMMU, which focuses on female biology. Both platforms use saliva-based epigenetic testing to help individuals track biological changes and better understand how lifestyle choices may influence their long-term health.

The partnership follows the recent appointment of Lisa Loud as CEO of DEPH Labs, where she is executing a vision to make sophisticated health technology easier to use while giving individuals direct control over their biological information. Loud brings decades of experience across technology, financial services, blockchain and digital privacy, having held senior leadership positions at Apple, PayPal, BitMEX, ShapeShift and Secret Network. 

About DEPH Labs

DEPH Labs is a precision health company combining DNA, epigenetics and artificial intelligence to transform complex biological data into personalized, actionable health insights. DEPH Holdings, Inc., a Texas-based company, is the parent company of DEPH Labs and ENGNE. The company has developed sex-specific epigenetic biological age technology and operates two dedicated precision health platforms, UMMU for women and ENGNE for men. Through at-home saliva testing, advanced biological analysis and personalized digital insights, DEPH Labs helps individuals better understand their biological age, track changes over time and make more informed decisions about their health and longevity. The company is also advancing a privacy-first approach to biological data, emphasizing individual ownership, granular control and programmable consent.

Contact

Founder
Lorcan Byrne
ForewordVenture
lorcan@forewordventure.com

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

AIXONA Announces AI-Powered Transaction Optimization and Expansion into European and Canadian Markets

Published

on

Singapore, Singapore, October 30th, 2026, FinanceWire

AIXONA today announced the active deployment of its proprietary AI-powered transaction optimization engine, launching alongside a strategic market expansion into Canada and the European Union. Engineered to eliminate fee friction across digital asset management workflows, the algorithm analyzes real-time blockchain congestion and multi-route execution pathways to dynamically identify and route transactions through the most cost-efficient channels available.

AIXONA’s AI optimisation engine is designed to analyse transaction conditions and identify opportunities to execute cryptocurrency transactions at lower cost. By assessing factors such as network fees and available transaction routes, the technology aims to help users reduce avoidable transaction expenses where more efficient options are available.

The company is combining this technology initiative with its expansion into additional international markets, broadening its focus beyond its Singapore base.

AI Technology Designed to Reduce Transaction Costs

Transaction fees remain an important consideration for cryptocurrency users. Costs can fluctuate depending on blockchain network congestion, transaction size, and the network being used.

AIXONA’s active AI optimisation engine is designed to assess relevant transaction conditions and identify potentially more cost-efficient execution options. Its purpose is to help users make better-informed transaction decisions and reduce costs where suitable opportunities exist.

The technology forms part of AIXONA’s wider approach to applying artificial intelligence to practical challenges in digital asset management.

Actual savings depend on transaction conditions and network availability, and lower fees cannot be guaranteed for every transaction.

International Expansion into the EU and Canada

Alongside its technology development, AIXONA is expanding its international presence across the European Union and Canada.

The expansion is intended to make the company’s digital asset management services accessible to a wider audience and support its growth in established financial and technology markets.

As part of this process, the company must take account of the regulatory and operational requirements applicable in each jurisdiction. The availability and scope of its services will depend on the relevant local requirements.

A Focus on Digital Asset Management

The cryptocurrency sector continues to develop, creating demand for tools that help users manage digital assets, monitor transactions, and understand the costs associated with blockchain activity.

AIXONA focuses on cryptocurrency management and blockchain-related technology, with an emphasis on accessibility, transaction efficiency, and a straightforward user experience.

The company’s approach combines digital asset management services with technology intended to improve transaction efficiency. Its AI optimisation engine represents one element of this broader focus.

About AIXONA

AIXONA is a digital asset management platform headquartered at 8 Marina Boulevard, Singapore 018981. The company focuses on cryptocurrency management and blockchain-related technology, including AI-powered transaction optimisation designed to identify opportunities for more cost-efficient cryptocurrency transactions.

AIXONA is expanding its international presence into the European Union and Canada as part of its broader business development strategy.

Headquarters: 8 Marina Boulevard, Singapore 018981

Website: https://aixona.com/

Contact

CMO
Jason Lee
AIXONA
customers@support-aixona.com

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Infinity Smiles Releases Medicare Dental Checklist for NY Seniors Ahead of Dec. 7 Deadline

Published

on

With Medicare open enrollment closing soon, Infinity Smiles urges older New York residents to look closely at dental benefits before choosing a plan.

Queens, New York, United States, 30th Oct 2026 — Many older adults find out only after losing a tooth that Original Medicare does not pay for most dental care, including dentures and dental implants. With Medicare open enrollment ending on December 7, Infinity Smiles, a dental practice in Flushing, is encouraging seniors and their families to check a plan’s dental benefits before they sign up for the year ahead.

Infinity Smiles Releases Medicare Dental Checklist for NY Seniors Ahead of Dec. 7 Deadline

Original Medicare (Parts A and B) generally does not cover routine dental services such as cleanings, fillings, extractions, dentures or implants. Some Medicare Advantage plans include dental benefits, but coverage varies widely from plan to plan, and many set annual dollar limits, waiting periods or restrictions on major procedures.

For seniors who are missing teeth or wearing dentures that no longer fit well, those details can mean the difference between getting treatment next year and putting it off.

“Every year we meet patients who assumed Medicare would help with dentures or implants and only learned otherwise when they needed treatment,” said Dr. Solomon Borukhov of Infinity Smiles. “Open enrollment is the main time of year seniors can change course. A few minutes spent reading the dental section of a plan can save a lot of stress and expense later.”

Dr. Solomon Borukhov recommends that seniors and the family members helping them ask these questions before choosing a plan:

  1. Does the plan include dental coverage at all? Original Medicare generally does not, so dental benefits usually come through a Medicare Advantage plan or a separate dental policy.
  2. What is the annual maximum? Many plans cap what they will pay each year, and the cap can be far below the cost of dentures or implants.
  3. Are dentures, implants and extractions covered, and at what percentage? Some plans cover only preventive care such as exams and cleanings.
  4. Are there waiting periods? Some plans require months of enrollment before covering major work.
  5. Is your current dentist in network? Out-of-network care can cost much more or not be covered.

“Missing teeth affect more than appearance,” Dr. Solomon Borukhov added. “They can make it harder to chew healthy foods and speak comfortably, and they can affect confidence. The good news is that seniors have more options today than many realize.” 

Options for replacing missing teeth now range from traditional full and partial dentures to mini dental implants, which can help stabilize loose dentures, and full-arch treatments such as All-on-X implants. The right choice depends on a patient’s oral health, bone support, budget and goals, which is why Dr. Solomon Borukhov encourages seniors to have an exam and a treatment discussion before deciding what coverage they need.

Before choosing a plan or booking a visit, patients should also check that their plan works at the practice. Infinity Smiles is in network with many PPO dental plans but does not currently accept HMO dental plans. Call the office at 929-346-4974 to ask whether your plan is accepted, or check the practice’s insurance page.

“Bring your plan’s benefit summary with you to your appointment,” Dr. Solomon Borukhov said. “We can explain what a treatment would involve and what it would cost, so you can compare that with what your plan says it will pay. If anything in the plan is unclear, your insurer or a Medicare counselor can answer it.” 

Seniors can review and compare plans at Medicare.gov or by calling 1-800-MEDICARE. Free and objective counseling is also available through the New York State Office for the Aging’s Health Insurance Information, Counseling and Assistance Program (HIICAP). Call 1-800-701-0501 and give your county to be connected to a local counselor.

Medicare open enrollment runs from October 15 through December 7, 2026.

About Infinity Smiles

Infinity Smiles is a dental practice in Flushing, New York, led by Dr. Solomon Borukhov. The practice provides preventive, restorative, cosmetic and implant dentistry, including exams and cleanings, gum disease therapy, root canal therapy, crowns and bridges, full and partial dentures, mini dental implants, All-on-X implants and full mouth reconstruction. The practice has served the Flushing community for more than 20 years and sees patients in English and Spanish. Learn more at infinitysmilesny.com.

Media Contact

Organization: Infinity Smiles

Contact Person: Dr.Solomon Borukhov

Website: https://infinitysmilesny.com/

Email: Send Email

Contact Number: +12202991644

Address: 143-05 41st Ave Flushing, NY 11355

City: Queens

State: New York

Country: United States

Release id: 50326

View source version on King Newswire:
Infinity Smiles Releases Medicare Dental Checklist for NY Seniors Ahead of Dec. 7 Deadline

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST